TrialJournal of clinical pharmacology2019

Updated Population Pharmacokinetic Model of Cabozantinib Integrating Various Cancer Types Including Hepatocellular Carcinoma.

Linh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.